CAR T plays rebound after Thursday slide

Kite Pharma Inc. (NASDAQ:KITE) and other developers of chimeric antigen receptor (CAR) T cell therapies recovered some of their losses Friday after dipping sharply Thursday on

Read the full 269 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE